Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (81)

Latest Posts

About This Stock More About This Stock
Ruling By FDA Causes Shares Of Esperion Therapeutics, Inc. To Jump 50% Today
Article By: Lorimer Wilson
Monday, March 20, 2017 3:23 PM EDT
Esperion announced this morning that the FDA is willing to sign off on an approval for its lead drug - provided it clears LDL lowering goals in a pivotal study - without a cardio study as a prerequisite. Its shares soared more than 50% on the news.
In this article: AMGN, ESPR
Read
Week In Review: BGI Genomics Plans $250 Million Shenzhen IPO
Article By: ChinaBio® Today
Saturday, March 18, 2017 1:45 PM EDT
BGI Genomics, the contract sequencing and diagnostics divisions of China genomics sequencing company BGI, filed to IPO on the Shenzhen Chi-Next exchange with a proposed target of raising $250 million.
In this article: PFE, AMGN
Read
AskSlim Market Week - Friday, March 17
Video By: Steve Miller
Friday, March 17, 2017 10:00 PM EDT
This was somewhat a typical FED week. S&P 500, the industrials, the Nasdaq, all have small gains for the week. Overall it was a quiet week.
In this video: AKS, NUE, UAL, ADBE, AMGN, BIIB, ORCL, SSYS, STLD, TSLA, WYNN, SPX
Watch
Amgen, Inc. Shares Plunge As Cholesterol Drug Not As Effective As Hoped
Article By: Lorimer Wilson
Friday, March 17, 2017 11:30 AM EDT
Amgen, Inc. shares plummeted 10% in Friday morning trading after the drug maker reported some positive findings about a key cholesterol drug that weren’t as good as many had hoped.
In this article: AMGN
Read
Cholesterol Stocks Clobbered: Good Clinical Results But High Expectations
Article By: Rod Raynovich
Friday, March 17, 2017 10:17 AM EDT
Results from a long-term study on the efficacy of a new generation of LDL cholesterol reducing drugs fell short of expectations and clobbered four stocks: AMGN, ESPR, MDCO and REGN.
In this article: AMGN, REGN, MDCO, ESPR Also: IBB, XBI, XLV
Read

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!